| pubmed-article:11886356 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11886356 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
| pubmed-article:11886356 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11886356 | lifeskim:mentions | umls-concept:C0025815 | lld:lifeskim |
| pubmed-article:11886356 | lifeskim:mentions | umls-concept:C0436548 | lld:lifeskim |
| pubmed-article:11886356 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:11886356 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11886356 | pubmed:dateCreated | 2002-3-11 | lld:pubmed |
| pubmed-article:11886356 | pubmed:abstractText | To investigate the efficacy of two different high doses of intravenous methylprednisolone (IVMP) during Multiple Sclerosis (MS) relapses. | lld:pubmed |
| pubmed-article:11886356 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11886356 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11886356 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11886356 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11886356 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11886356 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11886356 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11886356 | pubmed:issn | 0001-6314 | lld:pubmed |
| pubmed-article:11886356 | pubmed:author | pubmed-author:SavettieriGG | lld:pubmed |
| pubmed-article:11886356 | pubmed:author | pubmed-author:BuffaDD | lld:pubmed |
| pubmed-article:11886356 | pubmed:author | pubmed-author:PiazzaAA | lld:pubmed |
| pubmed-article:11886356 | pubmed:author | pubmed-author:FierroBB | lld:pubmed |
| pubmed-article:11886356 | pubmed:author | pubmed-author:ConteSS | lld:pubmed |
| pubmed-article:11886356 | pubmed:author | pubmed-author:SalemiGG | lld:pubmed |
| pubmed-article:11886356 | pubmed:author | pubmed-author:BrighinaFF | lld:pubmed |
| pubmed-article:11886356 | pubmed:author | pubmed-author:La BuaVV | lld:pubmed |
| pubmed-article:11886356 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11886356 | pubmed:volume | 105 | lld:pubmed |
| pubmed-article:11886356 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11886356 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11886356 | pubmed:pagination | 152-7 | lld:pubmed |
| pubmed-article:11886356 | pubmed:dateRevised | 2006-8-16 | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:meshHeading | pubmed-meshheading:11886356... | lld:pubmed |
| pubmed-article:11886356 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11886356 | pubmed:articleTitle | A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. | lld:pubmed |
| pubmed-article:11886356 | pubmed:affiliation | Institute of Neuropsichiatry, University of Palermo, Palermo, Italy. | lld:pubmed |
| pubmed-article:11886356 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11886356 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11886356 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11886356 | lld:pubmed |
